News
Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over ...
Mustang Bio stock surged over 180% on Monday after the FDA granted its brain cancer drug candidate an orphan drug designation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results